abacavir 600 MG / dolutegravir 50 MG / lamivudine 300 MG Oral Tablet [Triumeq]
RxNorm concept 1546894, branded drug (sbd). Prescribable name: Triumeq 600 MG / 50 MG / 300 MG Oral Tablet.
- RxCUI
- 1546894
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1546894 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Triumeq (abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG) Oral Tablet; Triumeq (abacavir 600 MG / dolutegravir 50 MG / lamivudine 300 MG) Oral Tablet; abacavir 600 MG / dolutegravir 50 MG / 3TC 300 MG Oral Tablet [Triumeq]; abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG Oral Tablet [Triumeq]
Related concepts
- lamivudine 300 MG (SCDC, consists of)
- abacavir 600 MG (SCDC, consists of)
- dolutegravir 50 MG (SCDC, consists of)
- abacavir 600 MG / dolutegravir 50 MG / lamivudine 300 MG [Triumeq] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Triumeq (BN, has ingredient)
- abacavir 600 MG / dolutegravir 50 MG / lamivudine 300 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 49702023113
- 50090160600
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1546894 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1546894 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1546894. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.